Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Corticosteroids in Post-COVID-19 Interstitial Lung Disease
NCT04988282Phase 4Completed
- Sponsor
- Turkish Thoracic Society
- Start
- May 2021
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in interstitial lung disease (ILD), sponsored by Turkish Thoracic Society. Started May 2021; status: completed.
02
Drugs
methylprednisolone
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT04988282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04988282.